2004
DOI: 10.1016/j.jconrel.2004.04.009
|View full text |Cite
|
Sign up to set email alerts
|

Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

13
427
0
5

Year Published

2007
2007
2016
2016

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 702 publications
(445 citation statements)
references
References 21 publications
13
427
0
5
Order By: Relevance
“…So a high initial release rate in the first few days after the implant is best for eliminating the intruding bacteria that are introduced during the implantation and systemically afterwards before they begin to proliferate. For the few bacteria that may survive the initial burst, a continued drug release is necessary to prevent their further population and inhibit the occurrence of latent infection [38]. So this 3-week prolonged drug release is considered to be an optimal treatment.…”
Section: Discussionmentioning
confidence: 99%
“…So a high initial release rate in the first few days after the implant is best for eliminating the intruding bacteria that are introduced during the implantation and systemically afterwards before they begin to proliferate. For the few bacteria that may survive the initial burst, a continued drug release is necessary to prevent their further population and inhibit the occurrence of latent infection [38]. So this 3-week prolonged drug release is considered to be an optimal treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Blending the bioactive factor into the polymer solution during electrospinning has been used to load proteins, 15,40,43,73 small molecules, 15,74 and nucleic acids [75][76][77] for release. Depending on the relative properties of the polymer and bioactive factors, this method can lead to the factors being homogenously dispersed in the fibers, 15 randomly dispersed in aggregates throughout the fibers, 15,73 or localized to the surface of the fibers.…”
Section: Bioactive Factor Loadingmentioning
confidence: 99%
“…Mostly PGA and PLA non-woven scaffolds were used in TE research [89][90][91]. These fibrous structures have high porosity (up to 95%) with interconnected pores and high surface area to volume ratio, though fibre diameter is confined in the range 10-15 µm.…”
Section: Textile Technologiesmentioning
confidence: 99%
“…This opportunity has been extensively exploited to load fibres with biomolecules that were intended to be released upon contact with the biological environment. Among the several drugs employed, antibiotics [87][88][89], anti-inflammatory drugs [90][91][92] and anticancer drugs [93] have been mainly investigated.…”
Section: "Composite" Electrospun Scaffoldsmentioning
confidence: 99%